Search for:

Mainland China’s NRDL: The expensive yet priceless ticket to market access

Recent updates in the NRDL highlight Mainland China’s improving market access and reimbursement environment for innovative therapies. However, this comes at the cost of heavy price cuts that manufacturers must offer in exchange for NRDL inclusion. Are these price cuts worth gaining market access in Mainland China? What other trends have emerged from the recent […]

Women’s leadership and COVID-19: Spotlight on Dr. Nandita Quaderi

At Clarivate we value every voice. With this ongoing series, we highlight women’s leadership role in accelerating innovation to address the COVID-19 pandemic. Watch the new video to learn more.   In this interview, we speak with Dr. Nandita Quaderi, Editor-in-Chief and Editorial VP, the Web of Science™, Clarivate. Nandita has a PhD in Molecular […]

Q&A: Five simple strategies to ensure regulatory compliance when globalizing your development program

Industry expert Lawrence Liberti shares his tips for tackling the complexity and diversity of regulatory requirements in divergent markets While expansion into new markets potentially introduces tremendous opportunities to scale your business, globalizing your development program doesn’t come without risks. Whether you’re a pharma or biotech from an established region looking to expand into an […]

Biopharma licensing finished with a strong Q4

During the fourth quarter of 2018, Cortellis Competitive Intelligence   registered 1,073 new deals (excluding mergers & acquisitions) with a total disclosed deal value of $46.1 billion as part of its ongoing coverage of licensing activity in the life sciences sector. The totals represented a 7.4% increase from 994 and a 41.4% increase from $27 billion […]

Optimizing patient-first clinical trials with advanced site intelligence [PODCAST]

Learnings from bringing clinical trial management in-house, and how to modernize your approach to patient-first trials with advanced data science, real-world data and other patient intelligence   One of the biggest challenges for the pharmaceutical industry is the efficiency of the product cycle for creating new medicines. A great determining step in that process is […]

Establishing an in-house medical equipment company: Q&A with Teresa Dail

In this interview, Teresa Dail, chief supply chain officer at Vanderbilt University Medical Center (VUMC), shares how organizations can set up an in-house process to provide medical equipment and supplies to both inpatients and patient homes. The following article has been edited for length and clarity.   Could you describe the environment before using internal […]

Structuring compensation for physicians with administrative duties

As healthcare organizations focus on expanding physician leadership, they may find themselves needing to determine how to compensate practicing providers for time spent on administrative duties. Research suggests that annual, hourly, or per-meeting stipends are typical compensation structures for part-time administrative responsibilities. But the real challenge often lies in determining a payment rate that’s fair […]